One of the largest American banks provides its employees with prescription medications.
Bank of America spends more than $250 million annually to cover the costs of GLP-1 type weight-loss drugs for its employees, according to CEO Brian Moynihan. The company’s leadership views this rapidly increasing expenditure as an investment in its workforce, CNBC reported.
Bank of America spends over $250 million annually to cover the costs of GLP-1 type weight-loss drugs for its employees, according to CEO Brian Moynihan. The company’s executives consider this rapidly increasing expenditure as an investment in its workforce, CNBC reported.
